Evolus, Inc. (EOLS)

From the record

Evolus, Inc.'s filings since 2017 show no warning events in the scan: no bankruptcy or receivership notice, no debt default notice, no exchange listing notice, no restatement warning, no auditor change, no material cyber incident and no late-report notice (its current reports).

From the record

Evolus, Inc.'s 8 filed years say what it did: it rose in 6 of 6 years; it never fell from a peak; net income was positive in 0 of 8 of those years (its annual reports).

From the record

Return on equity: in the fiscal year ended 2025-12-31, Evolus, Inc.'s shareholders' equity was below zero, so the profit on it is not read, and gross profitability: its products earned about 87 cents per dollar of everything the company owns. Leverage: it owed about 110 cents per dollar of assets, and net share issuance: its share count grew 4.0% over the year (the filed statements).

From the record

Evolus, Inc.'s standing among 315 graded names in its industry family: revenue of $297 million in fiscal 2025 ranks in the top 23% by size; a net margin of -17.4% ranks in the top 31%; revenue growth of 26% a year over the last 3 filed years ranks in the top 33% (its annual reports).

From the record

Evolus, Inc.'s leadership, from its insiders' filings and its current reports: the chief executive on the record is Moatazedi, David (President and Chief Executive Officer, as filed), filing under that title since 2018-05-08, 8.5 years (top 21% of its family); the 9 officers and directors filing in the last fifteen months have been on the record a median of 7.3 years (top 25%); 8 officer or director changes were reported on Form 8-K since 2023-11-13, against the 9 people in charge now (bottom 15%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

Evolus, Inc.'s room to grow, from the newest filed statements (fiscal 2025): cash of $54 million against debt of $146 million leaves -40.9% of its assets as net cash, bottom 2% of its family; cash from operations less capital spending is -15.4% of revenue (top 37%); a gross margin of 66.3% (bottom 44%); research spending of 3.2% of revenue (bottom 4%) (its annual report).

From the record

Evolus, Inc.'s growth drivers, from the filed years to fiscal 2025: the newest year grew 11.6% (top 45%); research spending grew 26.4% a year (top 17%); capital spending grew 28.6% a year (top 21%) (its annual reports). Evolus, Inc. reported 2 product lines in fiscal 2025: Product at $295 million (99%), Service at $2 million (1%); 2 of 2 grew against the year before (its annual report).

From the record

Evolus, Inc.'s newest year against its own record: revenue of $297 million in fiscal 2025 came in 16.6% below the $356 million its prior three years' pace pointed to (bottom 33% of its family); net income of $52 million against a prior three-year average of $62 million (top 49%); a net margin of -17.4% against -33.2% before (top 47%) (its annual reports).